PMC:7228307 / 49161-54061 19 Projects
Annnotations
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes | pubann:has_HGVS_notation |
---|---|---|---|---|---|---|
987 | 96-100 | Gene | denotes | FcγR | Gene:2213 | |
986 | 270-274 | Gene | denotes | FcγR | Gene:2213 | |
985 | 414-418 | Gene | denotes | FcγR | Gene:2213 | |
984 | 728-732 | Gene | denotes | FcγR | Gene:2213 | |
1010 | 815-819 | Gene | denotes | FcγR | Gene:2213 | |
1009 | 924-928 | Gene | denotes | FcγR | Gene:2213 | |
1008 | 1061-1065 | Gene | denotes | FcγR | Gene:2213 | |
1003 | 1261-1267 | Gene | denotes | CTLA‐4 | Gene:1493 | |
1004 | 1275-1280 | Gene | denotes | PD‐L1 | Gene:29126 | |
1005 | 1281-1285 | Gene | denotes | PD‐1 | Gene:5133 | |
1015 | 1383-1388 | Disease | denotes | tumor | MESH:D009369 | |
1011 | 1442-1455 | Chemical | denotes | Pembrolizumab | MESH:C582435 | |
1012 | 1457-1466 | Chemical | denotes | nivolumab | MESH:D000077594 | |
1013 | 1471-1481 | Chemical | denotes | cemiplimab | MESH:C000627974 | |
1006 | 1495-1499 | Gene | denotes | PD‐1 | Gene:5133 | |
1016 | 1530-1536 | Disease | denotes | cancer | MESH:D009369 | |
1017 | 1629-1634 | Mutation | denotes | S228P | rs1469294455 | |
1014 | 1703-1715 | Chemical | denotes | tremelimumab | MESH:C520704 | |
1007 | 1727-1733 | Gene | denotes | CTLA‐4 | Gene:1493 | |
1022 | 1951-1956 | Gene | denotes | FcγRI | Gene:2214 | |
1025 | 2137-2141 | Gene | denotes | PD‐1 | Gene:5133 | |
1023 | 2160-2165 | Gene | denotes | FcγRI | Gene:2214 | |
1024 | 2243-2250 | Gene | denotes | FcγRIIb | Gene:2213 | |
1034 | 2650-2665 | Chemical | denotes | N‐linked glycan | ||
1033 | 2694-2698 | Gene | denotes | FcγR | Gene:2213 | |
1035 | 2769-2781 | Chemical | denotes | Atezolizumab | MESH:C000594389 | |
1031 | 2796-2801 | Gene | denotes | PD‐L1 | Gene:29126 | |
1032 | 2866-2870 | Gene | denotes | FcγR | Gene:2213 | |
1046 | 2955-2959 | Gene | denotes | FcγR | Gene:2213 | |
1045 | 3003-3007 | Gene | denotes | FcγR | Gene:2213 | |
1047 | 3075-3082 | Chemical | denotes | leucine | MESH:D007930 | |
1048 | 3150-3157 | Chemical | denotes | alanine | MESH:D000409 | |
1051 | 3159-3170 | Mutation | denotes | L234A L235A | p.L234,235A,A | |
1044 | 3247-3251 | Gene | denotes | FcγR | Gene:2213 | |
1049 | 3305-3315 | Chemical | denotes | teplizumab | MESH:C502540 | |
1050 | 3320-3330 | Chemical | denotes | spesolimab | ||
1068 | 3416-3420 | Gene | denotes | FcγR | Gene:2213 | |
1066 | 3477-3481 | Gene | denotes | FcγR | Gene:2213 | |
1069 | 3592-3602 | Chemical | denotes | durvalumab | MESH:C000613593 | |
1063 | 3609-3614 | Gene | denotes | PD‐L1 | Gene:29126 | |
1070 | 3620-3631 | Chemical | denotes | anifrolumab | MESH:C582345 | |
1071 | 3718-3723 | Mutation | denotes | L234F | p.L234F | |
1072 | 3757-3762 | Mutation | denotes | L235E | p.L235E | |
1073 | 3786-3791 | Mutation | denotes | P331S | p.P331S | |
1067 | 3836-3840 | Gene | denotes | FcγR | Gene:2213 | |
1065 | 3873-3877 | Gene | denotes | FcγR | Gene:2213 | |
1064 | 3926-3929 | Gene | denotes | C1q | Gene:712 | |
1088 | 4021-4026 | Gene | denotes | FcγRI | Gene:2214 | |
1089 | 4031-4038 | Gene | denotes | FcγRIIb | Gene:2213 | |
1094 | 4054-4080 | Disease | denotes | PD‐1 antibody tislelizumab | MESH:D010300 | |
1091 | 4093-4097 | Gene | denotes | FcγR | Gene:2213 | |
1095 | 4209-4214 | Mutation | denotes | E233P | p.E233P | |
1096 | 4216-4221 | Mutation | denotes | F234V | rs755807976 | |
1097 | 4223-4228 | Mutation | denotes | L235A | p.L235A | |
1098 | 4256-4261 | Mutation | denotes | D265A | p.D265A | |
1090 | 4294-4298 | Gene | denotes | FcγR | Gene:2213 | |
1099 | 4359-4364 | Mutation | denotes | S228P | rs1469294455 | |
1100 | 4377-4382 | Mutation | denotes | L309V | p.L309V | |
1101 | 4387-4392 | Mutation | denotes | R409K | p.R409K | |
1093 | 4418-4428 | Chemical | denotes | disulfides | MESH:D004220 | |
1092 | 4596-4600 | Gene | denotes | FcγR | Gene:2213 | |
1105 | 4689-4693 | Gene | denotes | FcγR | Gene:2213 | |
1104 | 4820-4824 | Gene | denotes | FcγR | Gene:2213 |